astrocito-02.png

Astrocytes in Health                 And Dementia

London, UK

26th September 2019

The Speakers

Section 01

Basic science of astrocytes in vitro/preclinical

Luc Pellerin

Lausanne University, Switzerland

Anne-Karine Bouzier-Sore

Centre RMSB, France

Sarah Jolly 

 University College London, UK

Eduardo R. Zimmer 

UFRGS, Brazil

Section 02

Radiochemistry/design, translation, preclinical and human

Salvatore Bongarzone

King’s College London, UK

Diana Cash

King’s College London, UK

Igor Fontana

UFRGS, Brazil/King’s College London, UK

Section 03

In vivo astrocyte biomarkers

Nick Ashton

Gothenburg University, Sweden

Elena Rodriguez Vieitez

Karolinska Institute, Sweden

Christine Parker

 GSK/Imperial College London

Paul Edison

Imperial College London, UK

 

Programme

26th September

3 sessions; ~15min talks with open discussion/questions after each

08:30 – 09:00  |  Registration

09:00 – 09:15  |  Intro, thank sponsor(s), housekeeping etc

 

09:15 – 10:45 

Section 1 – Basic science of astrocytes in vitro/preclinical

 

Luc Pellerin |  Lausanne University, Switzerland 

Astrocytes as activity-dependent lactate suppliers for neurons: Key role for MCT4

Anne-Karine Bouzier-Sore  |  Centre RMSB, France

Importance of astrocytic lactate in brain metabolism: from functional brain imaging to neuroprotection

Sarah Jolly  |  University College London, UK

Targeting astrocytes in neurodegenerative diseases: from basic science to drug discovery

Eduardo R. Zimmer  |  UFRGS, Brazil

Astrocyte glutamate transport drives [¹⁸F]FDG-PET signal

10:45 – 11:15  |  Coffee break

 

11:15 – 12:15

Section 2 – Radiochemistry/design, translation, preclinical and human

Salvatore Bongarzone  |  King’s College London, UK

What we need to know to design a CNS PET radiotracer

Diana Cash  |  King’s College London, UK

Preclinical imaging and neuroinflammatory biomarkers

 

Igor Fontana  |  UFRGS, Brazil/King’s College London, UK  

Development of Carbon-11 PET Pro-Radiotracer for Imaging the Astroglial Excitatory Amino Acid Transporter

12:15 – 13:15  |  Lunch - Buffet provided

13:15 – 14:45 

Section 3 – In vivo astrocyte biomarkers

Nick Ashton  |  Gothenburg University, Sweden

The current status of fluid biomarkers in Alzheimer's disease and related disorders.

 

Elena Rodriguez Vieitez  |  Karolinska Institute, Sweden

PET imaging of astrocytosis using [¹¹C]-deuterium-L-deprenyl in translational and multimodal studies

 

Christine Parker  |  GSK/Imperial College London, UK

Development of a PET Ligand Targeting the Imidazoline-I2 Binding site – a potential astrocytic marker?

 

Paul Edison  |  Imperial College London, UK

Evaluation of astroglial activation using novel [11C]-BU99008 PET

14:45 – 15:15  |  Tea

 

15:15 – 16:30  |  “Open Mic” &/or group discussions to promote collaboration

 

16:30 – 17:00  |  Wrap-up/final discussion

The Venue

St Thomas' Hospital

4th floor Lambeth wing.

Westminster bridge road, SE17EH

London, UK

 
 

01

11

50

DAY
SPEAKERS
PARTICIPANTS
 

Astrocytes in Health And Dementia

THINKING AHEAD

What

Thinking AHEAD

When

26th September 2019

Where

St Thomas' Hospital

4th floor Lambeth wing

Westminster bridge road, SE17EH

London, UK

Contact Us

To learn more, don’t hesitate to get in touch

Website by IDEA-SCI